The summary below is from the full report titled “Effect of Recombinant Human Parathyroid Hormone (1-84) on Vertebral Fracture and Bone Mineral Density in Postmenopausal Women with Osteoporosis. A Randomized Trial.” It is in the 6 March 2007 issue of Annals of Internal Medicine (volume 146, pages 326-339). The authors are S.L. Greenspan, H.G. Bone, M.P. Ettinger, D.A. Hanley, R. Lindsay, J.R. Zanchetta, C.M. Blosch, A.L. Mathisen, S.A. Morris, and T.B. Marriott, for the Treatment of Osteoporosis with Parathyroid Hormone Study Group.
Parathyroid Hormone (1-84) and Risk for Spinal Fractures in Women with Osteoporosis. Ann Intern Med. 2007;146:I–20. doi: https://doi.org/10.7326/0003-4819-146-5-200703060-00001
Download citation file:
Published: Ann Intern Med. 2007;146(5):I-20.
Emergency Medicine, Endocrine and Metabolism, Metabolic Bone Disorders.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use